Switching patients with acromegaly from octreotide LAR to pasireotide LAR improves biochemical control: crossover extension to a randomized, double-blind, multicenter, Phase III study [PDF]
Pamela U. Freda +12 more
openalex +1 more source
Growth hormone in disease and treatment (Review). [PDF]
Fakir S +3 more
europepmc +1 more source
Real-world burden of disease, treatment, and healthcare resource utilization in acromegaly: a quantitative survey of patient experiences. [PDF]
Koobatian M +4 more
europepmc +1 more source
Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers [PDF]
Robert R. Henry +5 more
openalex +1 more source
Update on Medical Treatment of Cushing's Syndrome. [PDF]
Dillon BR +7 more
europepmc +1 more source
Pasireotide does not improve efficacy of aspiration sclerotherapy in patients with large hepatic cysts, a randomized controlled trial [PDF]
Titus F. M. Wijnands +5 more
openalex +1 more source
Clinical presentation, predictive factors and management of patients with Nelson syndrome: a retrospective study. [PDF]
Mazzeo P +8 more
europepmc +1 more source
Pasireotide as first line medical therapy for selected patients with acromegaly. [PDF]
Olarescu NC +6 more
europepmc +1 more source
Efficacy and Safety of Pasireotide Treatment in Acromegaly: A Systematic Review and Single Arm Meta-Analysis [PDF]
Turkan Aliyeva +4 more
openalex +1 more source

